First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, December 2013

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 2 followers.

First-in-human phase II trial of the botanical formulation PHY906 w/ capecitabine as second-line therapy in... http://t.co/nuV79X8aF9

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.